Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Relapse”

991 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 991 results

Not applicableStudy completedNCT05029206
What this trial is testing

Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Uppsala University 174
Large-scale testing (Phase 3)Ended earlyNCT01252355
What this trial is testing

Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta

Who this might be right for
Multiple Sclerosis Relapse
Sanofi 534
Post-approval studies (Phase 4)Ended earlyNCT02241785
What this trial is testing

Natalizumab as an Efficacy Switch in Participants With Relapsing Multiple Sclerosis After Failure on Other Therapies

Who this might be right for
Relapsing Multiple Sclerosis
Biogen 47
Not applicableStudy completedNCT05366036
What this trial is testing

Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-remitting
Eisai Korea Inc. 172
Post-approval studies (Phase 4)Active Not RecruitingNCT05090371
What this trial is testing

Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals 136
Post-approval studies (Phase 4)Study completedNCT01498887
What this trial is testing

Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 347
Large-scale testing (Phase 3)Looking for participantsNCT05834855
What this trial is testing

Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingDemyelinating Autoimmune Diseases, CNS+3 more
Amsterdam UMC, location VUmc 200
Post-approval studies (Phase 4)Ended earlyNCT00203047
What this trial is testing

Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 414
Not applicableStudy completedNCT03942952
What this trial is testing

PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingNeuromyelitis OpticaAcute Disseminated Encephalomyelitis+1 more
University of Texas Southwestern Medical Center 49
Testing effectiveness (Phase 2)Study completedNCT00333138
What this trial is testing

Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Novartis 281
Not applicableActive Not RecruitingNCT05797740
What this trial is testing

Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)

Who this might be right for
Multiple Sclerosis
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 367
Not applicableStudy completedNCT01925690
What this trial is testing

Development of a Motivational Intervention to Improve Treatment Adherence in MS

Who this might be right for
Relapsing-remitting Multiple Sclerosis
University of Missouri, Kansas City 80
Large-scale testing (Phase 3)Active Not RecruitingNCT04586010
What this trial is testing

Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Multiple Sclerosis
Hoffmann-La Roche 746
Not applicableStudy completedNCT01518660
What this trial is testing

Multiple Sclerosis and Progressive Resistance Training

Who this might be right for
Multiple Sclerosis (Relapsing Remitting)
University of Aarhus 35
Not applicableUnknownNCT05705986
What this trial is testing

Immunoregulatory Effect of Microparticle Delivered STING Agonist in the Control of Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)

Who this might be right for
Relapse Remitting Multiple Sclerosis
Thomas Jefferson University 40
Large-scale testing (Phase 3)Looking for participantsNCT05134441
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Immunic AG 1,050
Testing effectiveness (Phase 2)Ended earlyNCT02222948
What this trial is testing

Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Genzyme, a Sanofi Company 112
Not applicableStudy completedNCT01112345
What this trial is testing

An Observational Study for the Assessment of Compliance and Persistence to Rebif® Therapy of Patients With Relapsing-remitting Multiple Sclerosis (MS) and Evaluation of Potential Factors Influencing These Parameters

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 133
Testing effectiveness (Phase 2)Active Not RecruitingNCT06800404
What this trial is testing

"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)Multiple Sclerosis
Hope Biosciences Research Foundation 10
Testing effectiveness (Phase 2)WithdrawnNCT00104143
What this trial is testing

A4I Antagonist in Patients With Relapsing Multiple Sclerosis.

Who this might be right for
Multiple Sclerosis
Hoffmann-La Roche
Load More Results